Ambitious study will profile thousands of tumor samples to uncover novel biomarkers and therapeutic targets for cancer and inflammatory diseases…
- Announces Completion of Phase 1 Study of Elraglusib in Pediatric Patients - Prolonged and Durable Complete Responses (CRs) Observed…
MAINZ, Germany, July 17, 2025 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today that Ryan…
SAN DIEGO, July 17, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company” or “BioAtla”), a global clinical-stage biotechnology…
SHENZHEN, China, July 16, 2025 /PRNewswire/ -- Under the guidance of UNESCO and the United Nations International Cooperation Public Welfare…
-- Expanded funding builds on the initial agreement to accelerate development of Prime Editors for Cystic Fibrosis (CF) -- --…
CLEVELAND, July 15, 2025 /PRNewswire/ -- IdentifySensors Biologics, a leader in digital diagnostic technologies, has demonstrated that its electronic biosensors…
Revolutionary food supply testing startup unveils new name and branding to reflect the science and vision behind its breakthrough solutions.…
CHICAGO, July 15, 2025 /PRNewswire/ -- EVERSANA®, a leading provider of commercialization services to the global life sciences industry, today…
First-of-its-kind 1,000-patient clinical study will use RNA-based stool and saliva tests to detect colon polyps — early warning signs of colorectal…